| WF/Mol |
body weight |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
180.0 |
g |
2.0 |
4.47 |
body weighing method |
0.0 |
|
7 |
days |
|
101307 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 8 |
202.0 |
g |
3.0 |
8.49 |
body weighing method |
0.0 |
acf |
2 |
days |
|
101312 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
200.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
|
2 |
days |
|
101313 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
201.0 |
g |
3.0 |
7.35 |
body weighing method |
0.0 |
|
7 |
days |
|
101321 |
2585 |
| WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
30.0 |
g |
2.0 |
4.47 |
body weighing method |
0.0 |
sham acf |
7 |
days |
change from surgery weight |
101327 |
2585 |
| WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
4.0 |
g |
1.0 |
2.65 |
body weighing method |
0.0 |
acf |
7 |
days |
change from surgery weight |
101326 |
2585 |
| WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
20.0 |
g |
2.0 |
4.47 |
body weighing method |
0.0 |
sham acf |
4 |
days |
change from surgery weight |
101323 |
2585 |
| WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
3.0 |
g |
6.0 |
15.87 |
body weighing method |
0.0 |
acf |
7 |
days |
change from surgery weight |
101340 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
8.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
acf |
7 |
days |
change from surgery weight |
101342 |
2585 |
| WF/Mol |
body weight |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
197.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
4 |
days |
|
101294 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
184.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
7 |
days |
|
101306 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
188.0 |
g |
1.0 |
2.24 |
body weighing method |
0.0 |
|
4 |
days |
|
101303 |
2585 |
| WF/Mol |
body weight |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
190.0 |
g |
5.0 |
12.25 |
body weighing method |
0.0 |
sham acf |
2 |
days |
|
101311 |
2585 |
| WF/Mol |
body weight |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 8 |
187.0 |
g |
1.0 |
2.83 |
body weighing method |
0.0 |
acf |
4 |
days |
|
101314 |
2585 |
| WF/Mol |
body weight |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
204.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
sham acf |
7 |
days |
|
101319 |
2585 |
| WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 8 |
-12.0 |
g |
2.0 |
5.66 |
body weighing method |
0.0 |
acf |
2 |
days |
change from surgery weight |
101332 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
-14.0 |
g |
2.0 |
5.29 |
body weighing method |
0.0 |
acf |
2 |
days |
change from surgery weight |
101334 |
2585 |
| WF/Mol |
body weight |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
181.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
7 |
days |
|
101304 |
2585 |
| WF/Mol |
body weight |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
184.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
sham acf |
4 |
days |
|
101315 |
2585 |
| WF/Mol |
body weight |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
203.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
7 |
days |
|
101318 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
18.0 |
g |
1.0 |
2.24 |
body weighing method |
0.0 |
|
4 |
days |
change from surgery weight |
101325 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
-10.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
4 |
days |
change from surgery weight |
101324 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
34.0 |
g |
2.0 |
4.47 |
body weighing method |
0.0 |
|
7 |
days |
change from surgery weight |
101329 |
2585 |
| WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 10 days) then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
21.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
9 |
days |
change from surgery weight |
101330 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
29.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
9 |
days |
change from surgery weight |
101331 |
2585 |
| WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
-5.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
sham acf |
2 |
days |
change from surgery weight |
101333 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
180.0 |
g |
2.0 |
5.29 |
body weighing method |
0.0 |
acf |
9 |
days |
|
101309 |
2585 |
| WF/Mol |
body weight |
controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 8 |
189.0 |
g |
2.0 |
5.66 |
body weighing method |
0.0 |
acf |
2 |
days |
|
101310 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
192.0 |
g |
3.0 |
6.71 |
body weighing method |
0.0 |
|
4 |
days |
|
101317 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 8 |
193.0 |
g |
2.0 |
5.66 |
body weighing method |
0.0 |
acf |
7 |
days |
|
101320 |
2585 |
| WF/Mol |
body weight gain |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
-4.0 |
g |
2.0 |
5.29 |
body weighing method |
0.0 |
acf |
4 |
days |
change from surgery weight |
101322 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
-6.0 |
g |
1.0 |
2.45 |
body weighing method |
0.0 |
sham acf |
2 |
days |
change from surgery weight |
101335 |
2585 |
| WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
-1.0 |
g |
1.0 |
2.45 |
body weighing method |
0.0 |
sham acf |
4 |
days |
change from surgery weight |
101337 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
6.0 |
g |
1.0 |
2.24 |
body weighing method |
0.0 |
sham acf |
4 |
days |
change from surgery weight |
101339 |
2585 |
| WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 6 |
8.0 |
g |
2.0 |
4.9 |
body weighing method |
0.0 |
sham acf |
7 |
days |
change from surgery weight |
101341 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
23.0 |
g |
3.0 |
6.71 |
body weighing method |
0.0 |
sham acf |
7 |
days |
change from surgery weight |
101343 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
186.0 |
g |
2.0 |
5.29 |
body weighing method |
0.0 |
acf |
4 |
days |
|
101302 |
2585 |
| WF/Mol |
body weight |
controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
193.0 |
g |
3.0 |
6.71 |
body weighing method |
0.0 |
sham acf |
4 |
days |
|
101301 |
2585 |
| WF/Mol |
body weight |
controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
186.0 |
g |
1.0 |
2.24 |
body weighing method |
0.0 |
sham acf |
7 |
days |
|
101305 |
2585 |
| WF/Mol |
body weight |
controlled ramipril content drinking water (3 mg/kg/d) (for 10 days) then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
176.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
acf |
9 |
days |
|
101308 |
2585 |
| WF/Mol |
body weight |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 8 |
194.0 |
g |
3.0 |
8.49 |
body weighing method |
0.0 |
acf |
4 |
days |
|
101316 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 5 |
12.0 |
g |
3.0 |
6.71 |
body weighing method |
0.0 |
acf |
7 |
days |
change from surgery weight |
101328 |
2585 |
| WF/Mol |
body weight gain |
controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 8 |
-5.0 |
g |
2.0 |
5.66 |
body weighing method |
0.0 |
acf |
4 |
days |
change from surgery weight |
101336 |
2585 |
| WF/Mol |
body weight gain |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
body mass |
male |
days
| 7 |
-5.0 |
g |
2.0 |
5.29 |
body weighing method |
0.0 |
acf |
4 |
days |
change from surgery weight |
101338 |
2585 |